Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2012-12-05 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NICE (06300), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE SIGNOURET : revenue, balance sheet and financial ratios
SELARL PHARMACIE SIGNOURET is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NICE (06300),
this company of category PME
shows in 2016 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE SIGNOURET (SIREN 789766797)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 403 118 €
Net income
112 791 €
66 977 €
87 720 €
212 162 €
98 574 €
25 295 €
56 835 €
90 785 €
63 476 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
115 274 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4.5%
Revenue and income statement
In 2024, SELARL PHARMACIE SIGNOURET generates positive net income of 113 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 63 k€ -> 113 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
112 791 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 98%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
97.639%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.074%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
290.019
215.074
237.293
197.601
149.137
99.672
102.388
83.636
97.639
Financial autonomy
22.726
26.983
26.549
29.687
33.407
39.907
41.026
44.974
40.074
Repayment capacity
10.253
None
None
None
None
None
None
None
None
Cash flow / Revenue
5.217%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
97.642024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELARL PHARMACIE SIGNOURET (97.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.07%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of SELARL PHARMACIE SIGNOURET (40.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 150.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
187.425
164.27
181.283
180.631
159.816
178.331
200.96
191.859
150.562
Interest coverage
15.75
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
150.562024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-16 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE SIGNOURET (150.56) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE SIGNOURET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
196 086 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
36
0
0
0
0
0
0
0
0
Customer payment term (days)
11
0
0
0
0
0
0
0
0
Supplier payment term (days)
33
0
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE SIGNOURET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE SIGNOURET is estimated at
1 574 645 €
(range 1 096 558€ - 2 355 760€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1096k€1574k€2355k€
1 574 645 €Range: 1 096 558€ - 2 355 760€
NAF 5 année 2024
Valuation method used
Net Income Multiple
112 791 €
×
14.0x
=1 574 646 €
Range: 1 096 558€ - 2 355 760€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE SIGNOURET with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE SIGNOURET
What is the revenue of SELARL PHARMACIE SIGNOURET ?
The revenue of SELARL PHARMACIE SIGNOURET in 2016 is 1.4 M€.
Is SELARL PHARMACIE SIGNOURET profitable?
Yes, SELARL PHARMACIE SIGNOURET generated a net profit of 113 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE SIGNOURET ?
The headquarters of SELARL PHARMACIE SIGNOURET is located in NICE (06300), in the department Alpes-Maritimes.
Where to find the tax return of SELARL PHARMACIE SIGNOURET ?
The tax return of SELARL PHARMACIE SIGNOURET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE SIGNOURET operate?
SELARL PHARMACIE SIGNOURET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart